Director received an award of 1,381 TECH derivative securities | OQRO Insider tradesWhy it stands out
Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
- Transaction date
- Aug 17, 2026
- Reporting period
- Not applicable
- Filed with the SEC
- Aug 19, 2026
DirectorIndirect holdingGrant / award
Context
- Classification
grant award
Code A — grant or award
- Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
0000914190-26-000131
Filed / recordedAug 19, 2026, 8:47 PM UTC Added to OQROOct 2, 2026, 12:27 PM UTC Data qualityVerified: identifiers matched exactly Reporting personAmy E. Herr SecurityRestricted Stock Units TableDerivative (Table II) Transaction dateAug 17, 2026 Acquired / disposedAcquired (A) Ownership formIndirect — By significant other Footnotes from the filing
- Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
- 460 restricted stock units vest on each of 8/17/2027 and 8/17/2028, and 461 restricted stock units vest on 8/17/2029.
Around the same time
Compensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.